Clinical Trial

Stromal Vascular Cells for the Treatment of Diabetic Peripheral Neuropathy

Study acronym: SVFDPN
Completed
View on ClinicalTrials.gov →
Summary
This is an interventional open-label study to determine the safety and clinical performance of SVF cells in the treatment of Diabetic Peripheral Neuropathy.
Trial Details
NCT Number NCT07553468
Lead Sponsor Michael H Carstens
Conditions Diabetic Foot, Diabetic Peripheral Neuropathy
Enrollment 8 participants
Start Date 2024-12-01
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-28